MedTrace Logo

Pilot Study Evaluating Functional and Wellness Outcomes of the Shepherd CAN DO MS Program

NCT03954717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 111

Last updated 2023-08-02

No results posted yet for this study

Summary

The study evaluates the efficacy of the CAN DO Program for improving health, wellness, and quality of life in people with MS, and compares outcomes between people with MS who participate in the CAN DO Program to a control group of people with MS who do not participate in the CAN DO Program. The study also evaluates the impact of the CAN DO Program on support partners.

Conditions

Interventions

BEHAVIORAL

Shepherd CAN DO Program

CAN DO Shepherd is a four-day participatory program held at the Shepherd Center, in Atlanta, Georgia or people with MS. The four-day program comprises evidence-based, comprehensive, and personalized educational and experiential opportunities aimed at empowering and enabling a person with MS to live a health life beyond their MS.

Sponsors & Collaborators

  • Genzyme, a Sanofi Company

    collaborator INDUSTRY

  • Can Do Multiple Sclerosis

    collaborator UNKNOWN

  • Shepherd Center, Atlanta GA

    lead OTHER

Principal Investigators

  • Deborah Backus, PhD, PT · Shepherd Center, Atlanta GA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-14
Primary Completion
2022-03-11
Completion
2022-03-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03954717 on ClinicalTrials.gov